Research

Research & Analysis

In-depth AI-powered analysis of public companies, competitive landscapes, and market trends.

See Boeing (BA) Q2 2026 earnings preview: consensus revenue $24B, FCF inflection, 737/787 production, and margin trends.

Boeing Q2 2026 earnings preview: revenue, cash flow, and production ramp are in focus as BA targets positive FCF and margin recovery.

Zeta Global (ZETA) stock analysis: 2026 revenue up 29.7% to $1.3B, EBITDA margin 21.4%. See growth drivers and customer trends.

Amkor Technology (AMKR) Q2 2026 earnings preview highlights strong revenue growth, margin expansion, and advanced packaging momentum.

Celestica (CLS) Q2 2026 earnings preview highlights raised revenue guidance, strong YoY growth, and key segment drivers.

Exelixis (EXEL) Q2 2026 earnings preview highlights $633M consensus revenue and key growth drivers in RCC and NET.

F5, Inc. (FFIV) Q3 2026 earnings preview covers revenue guidance, EPS estimates, and key growth drivers for the quarter.

Explore leading public companies benefiting from increased peptide usage in 2026, including Dr. Reddy’s, Amphastar, and West Pharma.

Rambus (RMBS) guides Q2 2026 revenue to $199M with strong product growth and EPS outlook. See key earnings drivers and segment updates.

SpaceX (SPCX) 2026 analysis covers revenue growth, Starlink expansion, and AI investments driving future outlook.